China Network Point-of-care Glucose Testing Market Size & Outlook
China network point-of-care glucose testing market, 2016-2028 (US$M)
Related Markets
China network point-of-care glucose testing market highlights
- The China network point-of-care glucose testing market generated a revenue of USD 61.4 million in 2021 and is expected to reach USD 87.6 million by 2028.
- The China market is expected to grow at a CAGR of 5.2% from 2022 to 2028.
- In terms of segment, accu-chek inform ii was the largest revenue generating types in 2021.
- CareSens Expert Plus is the most lucrative types segment registering the fastest growth during the forecast period.
Network point-of-care glucose testing market data book summary
| Market revenue in 2021 | USD 61.4 million |
| Market revenue in 2028 | USD 87.6 million |
| Growth rate | 5.2% (CAGR from 2021 to 2028) |
| Largest segment | Accu-chek inform ii |
| Fastest growing segment | CareSens Expert Plus |
| Historical data | 2016 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | I-STAT, CareSens Expert Plus, Accu-Chek Inform II, StatStrip, HemoCue |
| Key market players worldwide | Roche Holding AG ADR, Abbott Laboratories, Nova Biomedical, Bayer AG, Danaher Corp |
Other key industry trends
- In terms of revenue, China accounted for 5.0% of the global network point-of-care glucose testing market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Asia Pacific, Japan network point-of-care glucose testing market is projected to lead the regional market in terms of revenue in 2028.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 87.6 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Network Point-of-Care Glucose Testing Market Scope
Network Point-of-Care Glucose Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China network point-of-care glucose testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to network point-of-care glucose testing market will help companies and investors design strategic landscapes.
Accu-chek inform ii was the largest segment with a revenue share of 49.51% in 2021. Horizon Databook has segmented the China network point-of-care glucose testing market based on i-stat, caresens expert plus, accu-chek inform ii, statstrip, hemocue covering the revenue growth of each sub-segment from 2016 to 2028.
China is projected to have the world’s largest diabetic population owing to rapid rise in incidence of the disease. In addition, rise in the prevalence of infectious diseases and lifestyle disorders, including cardiovascular diseases, is expected to boost the adoption of POC glucose testing devices, thereby positively impacting the market growth.
Presence of a large number of local POC glucose testing product manufacturers has been a key factor contributing to the revenue generated by China in Asia Pacific POC glucose testing market.
Reasons to subscribe to China network point-of-care glucose testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China network point-of-care glucose testing market databook
-
Our clientele includes a mix of network point-of-care glucose testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China network point-of-care glucose testing market , including forecasts for subscribers. This country databook contains high-level insights into China network point-of-care glucose testing market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
China network point-of-care glucose testing market size, by types, 2016-2028 (US$M)
China Network Point-of-Care Glucose Testing Market Outlook Share, 2021 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
